DE3871705D1 - 2,4-disubstituierte tetrahydrofuranderivate. - Google Patents

2,4-disubstituierte tetrahydrofuranderivate.

Info

Publication number
DE3871705D1
DE3871705D1 DE8888116989T DE3871705T DE3871705D1 DE 3871705 D1 DE3871705 D1 DE 3871705D1 DE 8888116989 T DE8888116989 T DE 8888116989T DE 3871705 T DE3871705 T DE 3871705T DE 3871705 D1 DE3871705 D1 DE 3871705D1
Authority
DE
Germany
Prior art keywords
disubstituted
tetrahydrofurane
derivatives
tetrahydrofurane derivatives
disubstituted tetrahydrofurane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8888116989T
Other languages
English (en)
Other versions
DE3871705T2 (de
Inventor
Elena Carceller
Javier Bartroli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Noucor Health SA
Original Assignee
J Uriach y Cia SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ES8702900A external-priority patent/ES2007121A6/es
Priority claimed from ES8802276A external-priority patent/ES2007534A6/es
Application filed by J Uriach y Cia SA filed Critical J Uriach y Cia SA
Application granted granted Critical
Publication of DE3871705D1 publication Critical patent/DE3871705D1/de
Publication of DE3871705T2 publication Critical patent/DE3871705T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/12Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
DE8888116989T 1987-10-13 1988-10-13 2,4-disubstituierte tetrahydrofuranderivate. Expired - Lifetime DE3871705T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES8702900A ES2007121A6 (es) 1987-10-13 1987-10-13 Un rpocedimiento para obtener derivados 2,4-disustituidos de tetrahidrofurado y 5-oxotetrahidrofurado.
ES8802276A ES2007534A6 (es) 1988-07-19 1988-07-19 Procedimiento para la obtencion de derivados 2,4-disustituidos de tetrahidrofurano.

Publications (2)

Publication Number Publication Date
DE3871705D1 true DE3871705D1 (de) 1992-07-09
DE3871705T2 DE3871705T2 (de) 1992-12-17

Family

ID=26154354

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888116989T Expired - Lifetime DE3871705T2 (de) 1987-10-13 1988-10-13 2,4-disubstituierte tetrahydrofuranderivate.

Country Status (5)

Country Link
US (1) US4997843A (de)
EP (1) EP0312040B1 (de)
JP (1) JPH01132582A (de)
DE (1) DE3871705T2 (de)
GR (1) GR3004793T3 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2010568A6 (es) * 1988-08-04 1989-11-16 Uriach & Cia Sa J Procedimiento para la obtencion de derivados 2,5-disustituidos de tetrahidrofurano.
ES2013834A6 (es) * 1989-01-30 1990-06-01 Uriach & Cia Sa J Procedimiento para la obtencion de derivados 4-sustituidos de 2-alcoxitetrahidrofurano.
ES2010145A6 (es) * 1989-03-02 1989-10-16 Uriach & Cia Sa J Procedimiento para la obtencion de derivados de la 2-picolilamina.
US5700817A (en) * 1992-06-30 1997-12-23 Pohang Iron & Steel Co., Ltd. Cyclic lipid derivatives as potent PAF antagonists
WO1994000447A1 (en) * 1992-06-30 1994-01-06 Pohang Iron & Steel Co., Ltd. Novel cyclic lipid derivatives as potent paf antagonists
ES2062943B1 (es) * 1993-03-23 1995-11-16 Uriach & Cia Sa J Nuevos derivados de la (2-metil-3-piridil) cianometilpiperazinas.
CN105873934A (zh) * 2013-12-20 2016-08-17 阿彻丹尼尔斯米德兰德公司 异己糖醇醚和碳酸酯的合成

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0178261A3 (de) * 1984-10-10 1986-12-30 Sandoz Ag Substituierte 2-Furanyl- oder -5-Oxo-2-furanyl-alkoxy-phosphorylalkylcyclimmoniumsalze
GB8504871D0 (en) * 1985-02-26 1985-03-27 Ici Plc Heterocyclic compounds

Also Published As

Publication number Publication date
DE3871705T2 (de) 1992-12-17
EP0312040B1 (de) 1992-06-03
US4997843A (en) 1991-03-05
JPH01132582A (ja) 1989-05-25
EP0312040A3 (en) 1990-07-25
EP0312040A2 (de) 1989-04-19
GR3004793T3 (de) 1993-04-28

Similar Documents

Publication Publication Date Title
LV5742B4 (lv) 3,5-divalizvietoti pirokatehina atvasinajumi
DE3783669D1 (de) Alpha-aryl-alpha-phenethyl-1h-1,2,4-triazol-1-propan-nitrile.
DE3763411D1 (de) 1,2,3,6-tetrahydro-5-nitro-pyrimidin-derivate.
FI875619A0 (fi) 6-benzoxazinyl- och 6-benzotiazonyl-2,3,4,5-tetrahydropyridazin-3-oner.
DE3887281D1 (de) 1,2,3,4-Tetrahydro-5-nitro-pyrimidin-Derivate.
DE3871705T2 (de) 2,4-disubstituierte tetrahydrofuranderivate.
DE3765646D1 (de) 2,5,6,7-tetranor-4,8-inter-m-phenylen-pgi2-derivate.
FI880552A (fi) Substituerade 2,6-substituerade pyridinfoereningar.
FI881829A0 (fi) 1,3-dioxaner.
DE3888097D1 (de) 1,2,3,4-Tetrahydro-5-nitro-pyrimidin-Derivate.
DE58903154D1 (de) 2,2-difluorcyclopropyl-derivate.
FI894455A0 (fi) 1,4-dihydropyridinderivat.
ES2015605B3 (es) 3,4-dihidro-2h-piranos.
FI880417A (fi) Foerfarande foer framstaellning av 14,15-substituerade lanosteroler.
DE3788163D1 (de) 1,3,5-Trithian-Derivate.
FI880081A0 (fi) 2,1-bensotiazepin-2,2-dioxid-5 -karboxylsyraderivat.
FI884599A0 (fi) Foerfarande foer framstaellning av 3,3-disubstituerade indoliner.
DE3874027D1 (de) 1,3-dithiol-2-yliden-derivate.
DE3780162T2 (de) Heribizide 4,5-dihydro-1h-1,2,4-triazol-3-carboxamid-derivate.
DE3777600D1 (de) Substituierte 1,3,4-oxathiazol-2-one-stabilisatoren.
FI880658A (fi) Oximetrar av 2,6-dioxabicyklo-/3,3,0/ oktanoner.
ATE76872T1 (de) 2,4-disubstituierte tetrahydrofuranderivate.
DE3761091D1 (de) 2,6-dimethyl-p-benzochinontetraalkylketale.
ATE54146T1 (de) 1,2,3,6-tetrahydro-5-nitro-pyrimidin-derivate.
ATE50254T1 (de) 3,4-dihydro-4-oxo-2h-1-benzopyranyloxy-alkansaeu e-derivate.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee